Zolinza ACT Program
 
MERCK
Zolinza® [vorinostat] capsules Reactivate Expression
Home Patient Product Information Physician Prescribing Information Helpful Resources Questions to Ask
Your Doctor Reimbursement Refer a Friend
Healthcare Professionals
Sign Up for UpdatesTo be notified by e-mail when updates are made
to this site

Reimbursement Through the ACT Program – Accessing Coverage Today

Merck & Co., Inc., knows that healthcare reimbursement can sometimes make it difficult to access the medications that patients need. To ease the process, we have created the ACT program to help those patients who have been prescribed ZOLINZA, as well as their caregivers.

Click below to read or download
the ACT program brochure
ACT program brochure
Download (PDF)
Click below to view or download the
ACT program enrollment form
ACT program enrollment form
Download (PDF)


Home | Refer a Friend | Patient Product Information | Physician Prescribing Information
ZOLINZA is a registered trademark of Merck & Co., Inc. Copyright © 2008 Merck & Co., Inc. All rights reserved.

This site is intended only for residents of the United States, its territories, and Puerto Rico.
20751234(1)-05/07-ZOL